- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02122250
Web-based Support for People With Type 2 Diabetes
Developing and Testing Accessible Web-based Support for Patient Self-management of Diabetes
This project will address vital questions regarding how best to design web-based materials for the growing population of patients with basic literacy and computer skills but lower levels of health literacy, building on our previous experience of developing web-based materials for people with lower levels of literacy and health literacy.
This study will be carried out two phases. Phase 1 will use qualitative methods to understand user experiences of the web-based materials through observational 'think-aloud' interviews with users. Phase 2 will test the newly developed web-based materials to a static (non-interactive) version of the materials online.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Potential participants are patients with Type 2 diabetes aged 18 years or more, who are able to consent.
Exclusion Criteria:
- Severe mental health problems, palliative care, recent bereavement, known opposition to involvement in research or inability to complete research measures, e.g. learning disability, inability to read / speak English.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Interactive web-based materials
Interactive web-based materials for self-management of diabetes
|
Interactive web-based materials for self-management of diabetes
|
|
Aktiver Komparator: Static web-based materials
Static version of the interactive web-based materials
|
Static web-based materials
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
user engagement
Zeitfenster: This will be measured by intervention completion rates
|
This will be measured by intervention completion rates
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Patient enablement
Zeitfenster: Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
|
Website satisfaction
Zeitfenster: Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
|
Physical activity attitudes and intentions
Zeitfenster: Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
|
Diabetes and Physical activity knowledge
Zeitfenster: Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Single item: whether you would recommend the website to others
Zeitfenster: Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Participants will be followed up as soon as they finished looking at the website, which is expected to be 20-40 minutes after they start the study.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Lucy Yardley, University of Southampton
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 4746
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Typ 2 Diabetes
-
Instituto Nacional de Ciencias Medicas y Nutricion...Aktiv, nicht rekrutierend
-
University of North Carolina, Chapel HillAmerican Heart AssociationRekrutierungTyp 2 Diabetes | Ernährung | Diabetes Typ 2 | T2DM (Typ-2-Diabetes mellitus) | Diabetes mellitis | T2DM | Diabetes-AufklärungVereinigte Staaten
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... und andere MitarbeiterNoch keine RekrutierungTyp 2 Diabetes | Diabetes mellitus Typ 2Türkei (türkiye)
-
Medical University of GrazAbgeschlossenTyp 2 Diabetes | Typ-2-Diabetes mellitus (T2DM) | Typ-2-Diabetes, InsulinpflichtigÖsterreich
-
Endogenex, Inc.Noch keine RekrutierungDiabetes mellitus, Typ 2 | Diabetes | Typ 2 Diabetes mellitus | Typ 2 Diabetes | Typ 2 Diabetes
-
Kaiser PermanenteThe Permanente Medical GroupAnmeldung auf EinladungTyp 2 Diabetes | Typ-2-Diabetes mellitus (T2DM) | Typ-2-Diabetes (T2D)Vereinigte Staaten
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)Noch keine Rekrutierung
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RekrutierungTyp 2 DiabetesVereinigte Staaten
-
Bnai Zion Medical CenterUnbekannt
-
Beijing HospitalRekrutierungPatienten mit Typ-2-Diabetes | T2DM (Typ-2-Diabetes mellitus) | T2DMChina
Klinische Studien zur Interactive web-based materials
-
Memorial Sloan Kettering Cancer CenterAbgeschlossenProstatakrebsVereinigte Staaten